Monopar Therapeutics | Uncategorized | Business Contracts

Description of Registered Securities (Filed With SEC on March 23, 2023)

Description of Registered Securities (Filed With SEC on March 24, 2022)

Employment Agreement of Kim Tsuchimoto effective November 1, 2017 (Filed With SEC on March 26, 2018)

Cancer Research UK Letter Dated March 21, 2018 (Filed With SEC on March 26, 2018)

Amendment One to Employment Agreement of Kim Tsuchimoto effective March 1, 2018 (Filed With SEC on March 26, 2018)

Consulting Agreement of pRx Consulting (Patrice Rioux) - effective January 1, 2018 (Filed With SEC on March 26, 2018)

Employment Agreement of Kirsten Anderson (Filed With SEC on March 26, 2018)

Consulting Agreement of pRx Consulting (Patrice Rioux) terminated December 31, 2017 (Filed With SEC on March 26, 2018)

Employment Agreement of Andrew P. Mazar effective November 1, 2017 (Filed With SEC on March 26, 2018)

Consulting Agreement of Andrew P. Mazar terminated October 31, 2017 (Filed With SEC on March 26, 2018)

Clinical Trial and Option Agreement with Cancer Research UK (Filed With SEC on March 26, 2018)

Consulting Agreement of Kim Tsuchimoto terminated October 31, 2017 (Filed With SEC on March 26, 2018)

Employment Agreement of Chandler D. Robinson effective November 1, 2017 (Filed With SEC on March 26, 2018)

Employment Agreement of Chandler D. Robinson terminated October 31, 2017 (Filed With SEC on March 26, 2018)

Amended and Restated 2016 Stock Incentive Plan (Filed With SEC on March 26, 2018)

Contribution Agreement (351) Containing Registration Rights Agreement with TacticGem (Filed With SEC on March 26, 2018)

Option and License Agreement with Onxeo S.A (Filed With SEC on March 26, 2018)

License Agreement with XOMA Ltd (Filed With SEC on March 26, 2018)

Monopar Therapeutics (62) | Uncategorized (18)